Cowen had $10.7 billion in assets under management as of April 1, 2017. We offer innovative products and solutions across the liquidity spectrum to institutional and private clients.
We attract talented investment teams as partners, providing seed and working capital and a robust institutional infrastructure to build sustainable investment businesses. Over decades, Cowen’s leadership has proven its ability to utilize balance sheet capital to build, grow and accelerate investment businesses that meet the changing needs of our clients.
The founding managing members of the investment management division (Peter Cohen, Thomas Strauss, Jeff Solomon, and the late Morgan Stark) have extensive experience derived from prior positions at the most senior levels in global capital markets and investment management.
We have an established network of relationships within the global financial community, as well as a seasoned perspective on the disciplines required to manage successful investment programs. In addition, we have assembled a professional support staff with their own extensive experience within their disciplines.
The founding managing members and senior-level professionals have collectively made significant personal investments in both the investment management division and, alongside Cowen’s clients, in most of the various portfolio strategies.
Multi-Sector Long/Short Equity
Margate is a multi-sector equity long/short alternative asset manager founded in April 2016 by Samantha Greenberg, a former partner at Paulson & Co. Inc. and veteran of Goldman Sachs’ Special Situations Group.
Margate pursues a thematic, catalyst-focused, fundamental long/short equity strategy, focused on the media, technology, communications, consumer discretionary and consumer staples sectors.
145 West 57th Street, 15th Floor
New York, NY 10019
T 212 609 0899
Ramius Advisors LLC (“Ramius”) pursues event driven and merger arbitrage strategies. Ramius employs a differentiated approach to investing in merger arbitrage that is driven by fundamental research and conviction.
The Ramius merger strategy is a focused portfolio of merger arbitrage transactions, seeking capital efficiency while managing risk through downside projections and dynamic trading.
Ethan JohnsonManaging Director, Partner, and Portfolio Manager, Ramius Merger Arbitrage Strategy212 201 4862
Andrew CohenManaging Director, Partner, and Risk Manager, Ramius Merger Arbitrage Strategy212 201 4860
599 Lexington Avenue
New York, NY 10022
T 212 201 4870
Quadratic is an innovative, woman-owned investment advisory firm focused on global macro strategies. Quadratic express its macroeconomic views primarily with liquid options and swaptions across FX, rates, equities, commodities, and credit.
Quadratic believes that options allow more effective risk management and can add additional alpha to macro themes by exploiting mispricings in volatility markets.
Nancy DavisChief Investment Officer, Quadratic203 340 2943
39 Lewis Street, 4th Floor
Greenwich, CT 06830
T 203 340 2943
Consumer Long/Short Equity
Caerus Investors builds high conviction long/short equity portfolios, based on fundamental research and deep knowledge of the consumer sector.
Our experienced team invests in longer duration ideas and has typically maintained low net exposure portfolios, seeking alpha from both long and short investments.
Ward DavisFounder, Managing Partner, Chief Investment Officer and Portfolio Manager, Caerus Investors212 488 5507
Brian AgnewManaging Partner and Portfolio Manager, Caerus Investors212 488 5522
599 Lexington Avenue
New York, NY 10022
T 212 201 4870
F 212 201 6214
Starboard Value LP is a New York-based investment adviser with a focused and fundamental approach to investing in publicly-traded US companies. Starboard invests in deeply undervalued companies and actively engages with management teams and boards of directors to identify and execute on opportunities to unlock value for the benefit of all shareholders.
Starboard’s principals have managed investments in this manner since 2002.
Cowen Healthcare Investments
Cowen Healthcare Investments was founded to capitalize on the tremendous pace of change and innovation in the healthcare sector. The team has considerable private biopharma investing experience and a disciplined investment history driven by deep diligence of underlying science.
We principally invest in mid- to late-stage private biopharma and digital health companies with scientifically validated targets, compounds, and technologies. We focus on companies with disruptive science, targeting a significant unmet medical need, and experienced management teams.
Kevin RaidyManaging Director and Portfolio Manager, Cowen Healthcare Investments646 562 1288
Healthcare Royalty Partners
HealthCare Royalty Partners is a multi-billion dollar global healthcare investment firm. Founded in 2006, HealthCare Royalty Partners has raised cumulative capital commitments of $3.5 billion to invest in commercial and near-commercial stage life science assets.
HealthCare Royalty Partners investments primarily consist of royalty purchases and debt or debt-like structures. This asset class offers uncorrelated yield and is typically protected by high barriers to entry.
RCG Longview invests in private real estate-related debt and equity opportunities. RCG Longview is uniquely aware of the opportunities and challenges facing real estate investors.
Extensive experience operating its own properties gives RCG Longview unparalleled perspective and enables it to quickly determine both the existing and the potential value of real estate — distinct advantages for developers and investors alike.
Michael BoxerFounding Partner, RCG Longview212 356 9200
7 Penn Plaza, Suite 1400
New York, NY 10001
T 212 356 9200
D 212 356 9243
Triartisan Capital Advisors
TriArtisan Capital Advisors is a private equity investing firm focused on making differentiated investments in public and private companies across a broad range of industries.
Our access to institutional capital enables us to make investments in middle and larger capitalization companies as either a lead sponsor or in partnership with many of the world’s leading private equity firms.
Gerald H. CromackManaging Director and Co-Founder, TriArtisan212 609 0621
Rohit ManochaManaging Director and Co-Founder, TriArtisan212 609 0622
Ed GrebowManaging Director, TriArtisan212 609 0626
830 3rd Avenue, 4th Floor
New York, NY 10022
T 212 609 0620
Cowen Growth Equity
Cowen’s growth equity investments are consistent with the organization’s focus on outperformance. We utilize our balance sheet to make direct investments in small- to medium-sized operating companies that demonstrate compelling risk/return characteristics. Our strong capital position enables us to take a longer horizon to realize value in our investments.
These investments span a diverse range of industries, including telecommunications, technology, clean tech, engineering and health care. We source and negotiate transactions with compelling risk/return characteristics.
Lee ChaikinManaging Director, Portfolio Manager212 845 7943
Jeff LibshutzManaging Director, Portfolio Manager212 201 4896
For more than two decades, we have demonstrated our ability to identify investment talent and build differentiated products and solutions. We translate that know-how to help investment teams - our partners - build sustainable investment businesses.
Thomas W. StraussVice Chairman, Cowen and Chairman, Investment Management212 845 7970
Fred S. FraenkelVice Chairman, Cowen and Interim Head, Investment Management212 845 7939